验证数据展示
经过测试的应用
Positive WB detected in | HepG2 cells, HEK-293 cells, MCF-7 cells, HeLa cells |
Positive IP detected in | HEK-293 cells |
Positive IHC detected in | human pancreas cancer tissue, human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | Chloroquine treated HeLa cells |
Positive FC (Intra) detected in | Jurkat cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:2000-1:10000 |
Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:250-1:1000 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
发表文章中的应用
WB | See 4 publications below |
CoIP | See 1 publications below |
产品信息
80294-1-RR targets P62,SQSTM1 in WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, IHC, IF/ICC, FC (Intra), IP, ELISA Application Description |
文献引用应用 | WB, CoIP |
经测试反应性 | human |
文献引用反应性 | human |
免疫原 | P62,SQSTM1 fusion protein Ag13131 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | sequestosome 1 |
别名 | P62/SQSTM1, P62, SQSTM1, Sequestosome-1, Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa |
计算分子量 | 48 kDa |
观测分子量 | 62 kDa |
GenBank蛋白编号 | BC017222 |
基因名称 | P62/SQSTM1 |
Gene ID (NCBI) | 8878 |
RRID | AB_2918883 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purification |
UNIPROT ID | Q13501 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Sequestosome 1 (SQSTM1/p62) is a multifunctional adaptor protein implicated in selective autophagy, cell signaling pathways, and tumorigenesis. p62 has been implicated in shuttling ubiquitinated and aggregated proteins for autophagic degradation. p62 is degraded during the autophagic process, which makes its intracellular level a marker for autophagy progression. p62 is at the cross-roads of several signaling pathways including Ras/ Raf/ MAPK and NFκB and plays important role in cancer. p62 is a component of inclusion bodies/ protein aggregates found in human diseases, including Huntington's disease, Alzheimer's disease, Parkinson's disease, and nephropathic cystinosis (PMID: 22074114, 22860231, 22714671).
实验方案
Product Specific Protocols | |
---|---|
WB protocol for P62,SQSTM1 antibody 80294-1-RR | Download protocol |
IHC protocol for P62,SQSTM1 antibody 80294-1-RR | Download protocol |
IF protocol for P62,SQSTM1 antibody 80294-1-RR | Download protocol |
IP protocol for P62,SQSTM1 antibody 80294-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
发表文章
Species | Application | Title |
---|---|---|
Front Pharmacol Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy | ||
Oncogene Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis | ||
Cell Oncol (Dordr) RAB37 suppresses the EMT, migration and invasion of gastric cancer cells by mediating autophagic degradation of β-catenin |